Antibodies for MHC-I, KIR2, KIR3, CD44, CD54, B7H1, CD16, NKG2D, MICA/B, KLGR1, CD45, CD3/16/56, CD8, CD3, CD4, GL3, NKp40, NKp30, NKp44, NKp46, and CD94 were purchased from Biolegend (San Diego, CA, USA). ULBP 1–6 antibodies were purchased from R&D Systems. Propidium iodide (PI) was purchased from Sigma (St. Louis, MO, USA). sAJ2 was prepared as described previously (35 (link)).
Isolating Oral Cancer Cells and Immune Cells
Antibodies for MHC-I, KIR2, KIR3, CD44, CD54, B7H1, CD16, NKG2D, MICA/B, KLGR1, CD45, CD3/16/56, CD8, CD3, CD4, GL3, NKp40, NKp30, NKp44, NKp46, and CD94 were purchased from Biolegend (San Diego, CA, USA). ULBP 1–6 antibodies were purchased from R&D Systems. Propidium iodide (PI) was purchased from Sigma (St. Louis, MO, USA). sAJ2 was prepared as described previously (35 (link)).
Corresponding Organization : University of California, Los Angeles
Other organizations : Poznan University of Medical Sciences
Variable analysis
- Cell lines used: oral squamous carcinoma cells and oral squamous carcinoma stem-like cells (OSCSCs) isolated from cancer patients with tongue tumors at UCLA
- Unclear from the information provided
- RPMI 1640 complete medium with 10% fetal bovine serum (FBS) (Gemini Bio-Product) used for cell cultures
- Alpha-MEM (Life Technologies, CA, USA) with 10% FBS used for OCs and DCs cultures
- M-CSF purchased from Biolegend (CA, USA)
- RANKL, GM-CSF, and IL-4 purchased from PeproTech (NJ, USA)
- Rh-IL-2 obtained from NIH-BRB
- Human CD3/CD28 T cell activator purchased from Stem Cell Technologies
- Antibodies purchased from Biolegend (San Diego, CA, USA) and R&D Systems
- Propidium iodide (PI) purchased from Sigma (St. Louis, MO, USA)
- SAJ2 prepared as described previously
- Not explicitly mentioned
- Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!